E693 40 (Opana ER 40 mg)
Generic Name: oxymorphone
Pill with imprint E693 40 is Yellow, Eight-sided and has been identified as Opana ER 40 mg. It is supplied by Endo Pharmaceuticals Inc..
Opana ER is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Opana ER 40 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for E693 40
Opana ER
- Generic Name
- oxymorphone
- Imprint
- E693 40
- Strength
- 40 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Eight-sided
- Availability
- Prescription only
- Drug Class
- Narcotic analgesics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Endo Pharmaceuticals Inc.
- National Drug Code (NDC)
- 63481-0693 (Discontinued)
- Inactive Ingredients
-
hypromelloses,
methylparaben,
sodium stearyl fumarate,
titanium dioxide,
triacetin,
FD&C Yellow No. 6,
D&C Yellow No. 10,
lactose monohydrate
Note: Inactive ingredients may vary.
Submitted by: Drugs.com
More about Opana ER (oxymorphone)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- 85 Reviews
- Drug class: narcotic analgesics
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.